معرفی
Michael G. Kaplitt, M.D., Ph.D. is a Professor of Neurological Surgery at Weill Cornell Medical College, with joint appointments in Neurology, Otolaryngology, and Neuroscience. He serves as the David and Ursel Barnes Professor in Minimally Invasive Surgery and practices at NewYork-Presbyterian Hospital.
- Education: M.D. (1995) and Ph.D. in Molecular Neurobiology (1993) from Tri-Institutional M.D.-Ph.D. Program
- Clinical Expertise: Movement Disorders, Parkinson's Disease, MRI-Guided Focused Ultrasound, Trigeminal Neuralgia, Deep Brain Stimulation, Epilepsy Surgery
His research focuses on gene therapy for neurological disorders, particularly Parkinson's and Huntington's diseases, with over 40 publications and two edited books. He leads clinical trials for novel treatments including focused ultrasound and gene transfer approaches. Scientific contributions include 2016's first FDA-approved gene therapy trial for Parkinson's Disease.
Key awards include the American Society for Gene Therapy Young Investigator Award (2005), Crain's 40 Under 40 (2004), and multiple 'Top Doctors' recognitions. He maintains editorial roles across journals and serves on Weill Cornell Medical School Committee on Admissions.
Collaborations include:
- Consultant at MeiraGTx, LLC
- Ownership interests in Graviton Bioscience Corporation and MeiraGTx, LLC
